MS-1819 Completed Phase 2 Trials for Cystic Fibrosis of Pancreas / Cystic Fibrosis (CF) / Cystic Fibrosis Gastrointestinal Disease Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04302662Phase 2 Combination Study With Escalating Doses of MS1819-SD on Top of a Stable Dose of PPEs